Skip to main content Back to Top
Advertisement

Pharmacotherapy

Anticoagulation-a Changing Landscape

James B. Groce, III, Pharm.D., CACP
Professor, Department of Pharmacy Practice
Campbell University College of Pharmacy and Health Sciences
Clinical Assistant Professor of Medicine
University of North Carolina School of Medicine
Clinical Pharmacy Specialist

ACPE activity # 0204-0000-16-457-H01-T
1 hour (0.1 CEU)

Pharmacy technicians, as part of the pharmacy team caring for patients on anticoagulation therapy, face a challenging role because there is a delicate balance between maintaining appropriate levels of anticoagulation and minimizing the potential risks associated with therapy. Pharmacy technicians must stay up-to-date as new information emerges that impacts how they participate upon the pharmacy team providing care for patients. Common anticoagulation challenges will be addressed and emerging information in this area of practice will be shared. Patient case discussions will provide pharmacy technicians with strategies for how to best work with the pharmacy team caring for patients on anticoagulation therapy.

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants will be able to

  • List traditional and emerging anticoagulant therapies.
  • Compare differences between traditional and emerging anticoagulants.
  • Identify the current challenges in clinical practice related to anticoagulation therapy.
  • Describe the role of the pharmacy technician in supporting patients receiving anticoagulation therapy.
  • On-Demand
  • CE Monograph

For Subscribers, Log In for CE Activities


New Drugs Update 2013

Melanie W. Pound, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Campbell University College of Pharmacy and Health Sciences
New Hanover Regional Medical Center
Buies Creek, North Carolina

ACPE activity # 0204-0000-13-466-H04-T
1 hour (0.1 CEU)

This activity will describe the new FDA-approved medications as well as introduce the new OTC products for 2013. Faculty will review the following prescription medications in terms of approved indications and pharmacology: fluticasone/vilanterol, vortioxetine, canagliflozin, alogliptin, dolutegravir and influenza vaccine. In addition, common adverse effects and drug interactions will be discussed for the prescription products.

  • Identify the FDA-approved medications for 2013.
  • Identify the new OTC products available in 2013.
  • Explain the indications and pharmacology of the following new prescription products: fluticasone/vilanterol, vortioxetine, canagliflozin, alogliptin, dolutegravir and influenza vaccine.
  • Describe the common adverse events and drug interactions associated with the new medications.
  • Podcast
  • On-Demand
  • CE Monograph

For Subscribers, Log In for CE Activities


New Drugs Update 2014

Melanie W. Pound, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Campbell University College of Pharmacy & Health Sciences
Buies Creek, North Carolina

ACPE activity #0204-0000-14-710-H04-T
1 hour (0.1 CEU)

This activity will describe the new FDA-approved medications for 2014. Faculty will review the following prescription medications in terms of approved indications and pharmacology: diabetes medications-dapagliflozin, empagliflozin, albiglutide; antibiotics-dalbavancin, oritavancin, tedizolid; cardiovascular medication-vorapaxar and the COPD medication, olodaterol. In addition, common adverse effects and drug interactions will be discussed for the prescription products.

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants will be able to

  • Identify the FDA-approved medications for 2014.
  • Explain the indications and pharmacology of the following prescription products: dapagliflozin, empagliflozin, albiglutide, dalbavancin, oritavancin, tedizolid, vorapaxar and olodaterol.
  • Describe the common adverse events and drug interactions associated with the new medications.
  • Podcast
  • On-Demand
  • CE Monograph

For Subscribers, Log In for CE Activities


New Drugs Update 2015

Melanie W. Pound, Pharm.D., BCPS
Wilmington, North Carolina

ACPE activity # 0204-0000-14-456-H04-T
1 hour (0.1 CEU, no partial credit)

This activity will describe the new FDA-approved medications for 2015. Faculty will review the following prescription medications in terms of approved indications, pharmacology, common adverse effects and drug interactions: antimicrobials-ceftazidime/avibactam and isavuconazonium; cardiovascular medications-alirocumab, edoxaban, ivabradine, and sacubitril/valsartan; and an adjunctive therapy for depression, brexpiprazole. In addition, a significant new dosage form of insulin glargine (U-300) will be discussed briefly.

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants will be able to

  • Identify the FDA-approved medications for 2015.
  • Explain the indications and pharmacology of the following prescription products: alirocumab, brexpiprazole, ceftazidime/avibactam, edoxaban, isavuconazonium, ivabradine, and sacubitril/valsartan.
  • Describe common adverse events and drug interactions associated with selected FDA-approved medications for 2015.
  • Compare and contrast insulin glargine U-300 and standard insulin glargine.
  • On-Demand
  • CE Monograph

For Subscribers, Log In for CE Activities


Overview of Critical OTC and Self-Care Issues - A Primer for Pharmacy Technicians

Daniel Krinsky, M.S., B.S.Pharm.
Associate Professor Department of Pharmacy Practice
Northeast Ohio Medical University College of Pharmacy
Manager, MTM Services
Giant Eagle Pharmacy
Ravenna, Ohio

ACPE activity #0204-0000-14-480-H01-T
1 hour (0.1 CEU)

This presentation will review key information about commonly used OTC products, the types of questions technicians should be asking consumers/patients, information to document about OTCs during the medication reconciliation process, and various safety concerns regarding these products.

Learning Objectives
At the conclusion of this knowledge-based educational activity, participants will be able to

  • Describe the pharmacy technician's role in patient care regarding OTC management
  • Explain the importance of identifying OTC product use during the process of medication reconciliation
  • Identify key safety concerns associated with certain OTC products
  • Podcast
  • On-Demand
  • CE Monograph

For Subscribers, Log In for CE Activities